|
|
 |
|
Viewing report
|
|
|
|
Breast Cancer Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., Oct 2006, Pages: 563
This report analyzes the worldwide markets for Breast Cancer Therapeutics in US$ Million. The major product segments analyzed are Hormonal Therapy, Chemotherapy, and Innovative Therapy. The report provides separate comprehensive analytics for the USA, Europe and Rest of World. Annual forecasts are provided for the period of 2000 through 2010. The report profiles 102 companies including many key and niche players worldwide such as Abraxis Bioscience Inc., Aeterna Zentaris Inc., Agendia BV, Aphton Corp., Array BioPharma Inc., AstraZeneca Plc, Bristol Myers Squibb, Dendreon Corporation, Eli Lilly and Company, Genentech Inc., Genta Inc., Novartis AG, Pfizer Inc., Roche Group, Sanofi-Aventis, Schering AG, Therion Biologics Corporation, and ViRexx Medical Corp. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on 'Enquire before buying'
Customers who bought this item also bought
U.S. Breast Cancer Therapeutics Markets
Analytical Tool - Breast Cancer
Analytical Tool - Breast Cancer Therapeutics & Competitive Insights
Cancer Therapeutics Markets
Breast Cancer - Therapeutic And Competitive Insights
Cancer Drug Discoveries: What the Future Holds: Breast Cancer Chapter
Drug Targets for Breast Cancer
Drug Targets for Breast Cancer
Prostate and Breast Cancer- New Treatments & Developmental Progress
Antibody Drug Targets and Focus on Breast & Prostate Cancer
Strategic Analysis of the Global Breast Cancer Therapeutics Pipeline
Breast Cancer Opinion Leader Forum
|
|
|
|
